Pelcitoclax
3-[1-[(3R)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acid
Molecular Identity
Pelcitoclax
3-[1-[(3R)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acid
PubChem CID: 76900653
2D Structure
Properties
C57H66ClF4N6O11PS4
Molecular Formula
1281.90
Molecular Weight
g/mol
1280.3035
Exact Mass
Da
7.5
XLogP
Above Lipinski threshold
275
TPSA
May have limited oral absorption
4
H-Bond Donors
21
H-Bond Acceptors
2490
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Pelcitoclax1619923-36-2APG-1252APG1252317UBD60MLRefChem:170705APG 1252Bcl-2/Bcl-XL Inhibitor APG-1252Pelcitoclax [INN]UNII-317UBD60MLAPG 1252 [WHO-DD]3-[1-[(3R)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acidPELCITOCLAX [WHO-DD]orb1693344CHEMBL4802151
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Pelcitoclax
Loading drug network...